Is There Finally a Cure For Breast Cancer?

The medical community was astounded by the recent news that an Indian teenager found a breast cancer cure. Krtin Nithiyandam, who lives in Epsom Surrey, claims that he has found a way to treat triple-negative breast cancer, a specific form of the disease that does not respond to most treatment methods.

Typical breast cancer treatments revolve around hormone therapy, as the condition is often caused by fluctuations of estrogen, progesterone, or certain growth chemicals. Treatment plans involve patients taking drugs that block excessive production of these hormones. These drugs are normally quite effective. However, triple-negative breast cancer – which affects around 7,500 women each year – is a special case. Doctors speculate that several factors cause the condition, thus, changing treatment. Those who are diagnosed with this illness usually have a combination of surgery, radiation, and chemotherapy; and even then, complete eradication of the disease is not certain.

Image Source: medicinenet.com
Image Source: medicinenet.com

Nithiyandam, who won the Google Science Fair in 2015 for developing a test that spots Alzheimer’s 10 years before it surfaces, says that he has found a way to change triple negative breast cancer cells so that they respond positively to treatment. The cells, which medical professionals call undifferentiated, do not have receptors which traditional cancer drugs latch on to. Nithiyandam says that blocking a specific protein in the cell could potentially build receptors.

Image Source: rd.com
Image Source: rd.com

Nithiyandam’s findings are currently being reviewed and tested by different medical groups. If proven, it could significantly improve the prognosis of the thousands of women battling breast cancer.

Sandra Balan is a passionate supporter of the American Cancer Society. She is constantly on the lookout for the latest cancer treatment news. You can learn more by liking this Facebook page.

New Study Shows Malaria Drug Can Be Used To Treat Cancer

Image Source: indiatimes.com
Image Source: indiatimes.com

A new study published in Nature Communications claims that an old malaria treatment drug can be used to reduce cancerous tumors. The drug, called atovaquone, was tested on mice which had tumors with low oxygen levels.

Scientists have found that cancer cells repair themselves faster in low oxygen environments. This is why radiotherapy is often considered hazardous, since cancer cells have the potential to grow faster after therapy. Tumors with low oxygen levels are typically more challenging to treat and usually metastasize to other areas.

However, it was found that atovaquone helps oxygenate the tumors so that they are more thoroughly destroyed during radiotherapy sessions. The malaria drug was tested on different sets of tumors and was seen to be effective for different types of cancers such as lung, head, neck, and brain cancer. Since this is an older medicine – and one used for a different illness altogether – it is readily available over the counter and from generic medicine manufacturers.

Image Source: pharmatimes.com
Image Source: pharmatimes.com

Authors of the study caution the public that results are from research in the initial stages and the medicine should not be considered a comprehensive treatment for cancer. Further research is necessary before oncologists will use atovaquone as a supplement for radiotherapy sessions. Yet this is an exciting discovery that opens doors to “new” treatments for cancer from other illness drugs.

Scientists and health professionals still do not understand the exact mechanics of the genesis of different forms of cancer, so cancer treatment has been in a protracted state of research. By testing other drugs and treatment, oncologists hope to reverse-deduce how cancer develops and thus effectively treat and/or prevent it.

Sandra Balan is a strong supporter of the American Cancer Society and actively looks for the latest news on cancer treatments. To learn more about developments in research, follow this Twitter account.